169 related articles for article (PubMed ID: 26155324)
21. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
[TBL] [Abstract][Full Text] [Related]
22. Efinaconazole 10% solution in the treatment of onychomycosis of the toenails.
Joseph WS; Vlahovic TC; Pillai R; Olin JT
J Am Podiatr Med Assoc; 2014; 104(5):479-85. PubMed ID: 25275736
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
[TBL] [Abstract][Full Text] [Related]
24. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
Gupta AK; Venkataraman M; Shear NH; Piguet V
Dermatol Ther; 2020 Jul; 33(4):e13613. PubMed ID: 32418289
[TBL] [Abstract][Full Text] [Related]
25. Managing Assessments and Expectations: Patient Responses Following Therapy With Efinaconazole Topical Solution, 10%.
Bhatia N
J Drugs Dermatol; 2015 Jul; 14(7):694-8. PubMed ID: 26151785
[TBL] [Abstract][Full Text] [Related]
26. Efinaconazole in Onychomycosis.
Gupta AK; Talukder M
Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
[TBL] [Abstract][Full Text] [Related]
29. How effective is efinaconazole in the management of onychomycosis?
Gupta AK; Cernea M
Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
[TBL] [Abstract][Full Text] [Related]
30. Topical treatment of onychomycosis with efinaconazole solution 10%.
Rich P
Cutis; 2013 Jun; 91(6):305-7. PubMed ID: 23837154
[TBL] [Abstract][Full Text] [Related]
31. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
Gupta AK; Studholme C
Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
[TBL] [Abstract][Full Text] [Related]
32. Efinaconazole Topical Solution, 10%: Factors Contributing to Onychomycosis Success.
Pollak RA; Siu WJJ; Tatsumi Y; Pillai R
J Fungi (Basel); 2015 Jul; 1(2):107-114. PubMed ID: 29376902
[TBL] [Abstract][Full Text] [Related]
33. Topical therapy for toenail onychomycosis: an evidence-based review.
Gupta AK; Daigle D; Foley KA
Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of combination therapy with efinaconazole 10% solution and 1064 nm Nd:YAG laser for treatment of toenail onychomycosis.
Bonhert K; Dorizas A; Sadick NS
J Cosmet Laser Ther; 2019; 21(3):179-183. PubMed ID: 30052090
[TBL] [Abstract][Full Text] [Related]
35. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
36. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
Gupta AK; Pillai R
J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R
J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
[TBL] [Abstract][Full Text] [Related]
38. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
Vlahovic TC; Gupta AK
Expert Rev Anti Infect Ther; 2022 Jan; 20(1):3-15. PubMed ID: 34106031
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies.
Gupta AK; Hall S; Zane LT; Lipner SR; Rich P
J Dermatolog Treat; 2018 Feb; 29(1):44-48. PubMed ID: 28521541
[TBL] [Abstract][Full Text] [Related]
40. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
Del Rosso JQ
J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
